DEF 14A: Aptose Biosciences Seeks Shareholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

Aptose Biosciences is asking shareholders to approve a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement and enhance the marketability of its shares.

Summary

• Aptose Biosciences Inc. is holding a special meeting of shareholders on January 27, 2025, to vote on a proposal to authorize a reverse stock split of its outstanding shares.
• The proposed reverse stock split would be at a ratio in the range of 1-for-10 to 1-for-30, with the exact ratio and effective date to be determined by the Board of Directors.
• The primary reason for the reverse stock split is to regain compliance with the Nasdaq's minimum bid price requirement of $1.00 per share.
• As of December 24, 2024, the closing price of Aptose's shares was $0.23, and there were 60,181,183 shares issued and outstanding.
• If the reverse stock split is implemented at the minimum ratio of 10-to-1, there would be approximately 6,018,118 shares outstanding, and at the maximum ratio of 30-to-1, there would be approximately 2,006,039 shares outstanding.
• The Board of Directors believes that the reverse stock split is in the best interests of the company and its shareholders.
• Shareholders will also vote on a proposal to approve one or more adjournments of the meeting, if necessary, to solicit additional proxies.
• The Board recommends that shareholders vote FOR both proposals.

Sentiment

Score: 6

Explanation: The document is primarily factual and procedural, outlining the reasons for and mechanics of the proposed reverse stock split. While the company expresses optimism about the potential benefits, there are also acknowledged risks and negative perceptions associated with reverse stock splits. The sentiment is neutral to slightly positive.

Positives

• Maintaining the Nasdaq listing is crucial for Aptose to retain access to capital markets and investor confidence.
• A higher share price may attract institutional investors and improve marketability.
• The Board has the flexibility to determine the exact reverse stock split ratio within the approved range to optimize its impact.
• The company has obtained conditional approval from the TSX for the reverse stock split.

Negatives

• Reverse stock splits can be perceived negatively by some investors.
• The share price may not increase proportionally to the reverse stock split ratio.
• Liquidity could be adversely affected by the reduced number of shares outstanding.
• The company has experienced a decline in its market price in its last reverse stock splits and may likely experience a similar decline in market price in relation to this Reverse Stock Split as well.

Risks

• The market price of the shares may decline after the reverse stock split.
• The reverse stock split may not attract new investors or satisfy institutional investor guidelines.
• The trading liquidity of the shares may not improve.
• Some stockholders may end up owning odd lots of shares, which can be more difficult to sell.
• The Corporation had experienced a decline in its market price in its last reverse stock splits and may likely experience a similar decline in market price in relation to this Reverse Stock Split as well.

Future Outlook

The company aims to regain compliance with Nasdaq's minimum bid price requirement by March 31, 2025, through the reverse stock split or by achieving a closing bid price of at least $1.00 for a minimum of ten consecutive business days.

Management Comments

• The Board is of the opinion that it may be in the best interests of the Corporation and the Shareholders to proceed with the Reverse Stock Split in order to both: (i) maintain the Nasdaq listing; and (ii) enhance the marketability of the Shares.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low share prices. They are often used to improve the perception of the stock and attract a broader range of investors.

Comparison to Industry Standards

• Many biotechnology companies with promising but yet-to-be-commercialized products have faced similar situations and opted for reverse stock splits to maintain exchange listings.
• For example, companies like Geron Corporation and BioTime have previously implemented reverse stock splits to comply with Nasdaq requirements.
• The success of a reverse stock split in improving a company's long-term prospects depends on various factors, including the company's underlying financial health and future growth potential.

Stakeholder Impact

• Shareholders will be affected by the reverse stock split, potentially seeing a change in the number of shares they own and the market price per share.
• Employees may be affected by the company's ability to maintain its Nasdaq listing, which could impact its long-term viability.
• The company's ability to attract investors and raise capital could be affected by the reverse stock split.

Next Steps

• Shareholders will vote on the reverse stock split proposal at the special meeting on January 27, 2025.
• If approved, the Board will determine the exact reverse stock split ratio and effective date.
• The company will file articles of amendment to implement the reverse stock split.
• Registered shareholders will be required to exchange their old share certificates for new ones or a DRS Advice/Statement.

Key Dates

Keywords

reverse stock split, Nasdaq, minimum bid price, shareholders, listing, Aptose Biosciences, shares